Cutler Group LP Sage Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$16.75 - $48.98 $50,250 - $146,940	3,000 New	3,000 $5,000
Q1 2023 May 01, 2023	SELL	$37.27 - $46.57 $55,905 - $69,855	-1,500 Reduced 88.24%	200 $0
Q4 2022 Feb 07, 2023	SELL	$32.2 - $43.61 $38,640 - $52,332	-1,200 Reduced 41.38%	1,700 $0
Q3 2022 Oct 25, 2022	SELL	$32.28 - $43.27 $48,420 - $64,905	-1,500 Reduced 34.09%	2,900 $5,000
Q2 2022 Aug 04, 2022	BUY	$27.52 - $37.99 $68,800 - $94,975	2,500 Added 131.58%	4,400 $5,000

Q1 2022 Apr 14, 2022	SELL	$30.71 - $45.71 $442,224 - $658,224	-14,400 Reduced 88.34%	1,900 $1,000
Q4 2021 Jan 18, 2022	BUY	$37.06 - $47.11 $541,076 - $687,806	14,600 Added 858.82%	16,300 $0
Q3 2021 Oct 26, 2021	SELL	$40.26 - $57.37 $148,962 - $212,269	-3,700 Reduced 68.52%	1,700 $1,000
Q2 2021 Jul 19, 2021	BUY	$54.88 - $79.29 $71,344 - $103,077	1,300 Added 31.71%	5,400 $6,000
Q1 2021 Apr 26, 2021	SELL	$70.65 - $96.76 $70,650 - $96,760	-1,000 Reduced 19.61%	4,100 $39,000
Q4 2020 Jan 21, 2021	BUY	$58.41 - $89.06 $40,887 - $62,342	700 Added 15.91%	5,100 $101,000
Q3 2020 Oct 27, 2020	SELL	$41.13 - $62.45 $16,452 - $24,980	-400 Reduced 8.33%	4,400 $34,000
Q2 2020 Jul 22, 2020	BUY	$25.95 - $43.15 $121,965 - $202,805	4,700 Added 4700.0%	4,800 $8,000
Q1 2020 May 07, 2020	SELL	$26.15 - $77.24 $721,740 - $2.13 Million	-27,600 Reduced 99.64%	100 $0
Q4 2019 Feb 06, 2020	BUY	$60.18 - $154.77 $974,916 - $2.51 Million	16,200 Added 140.87%	27,700 $45,000
Q3 2019 Oct 28, 2019	BUY	$140.29 - $189.96 $701,450 - $949,800	5,000 Added 76.92%	11,500 $77,000
Q2 2019 Aug 09, 2019	SELL	$157.85 - $183.09 $4.7 Million - $5.46 Million	-29,800 Reduced 82.09%	6,500 $187,000
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $1.12 Million - $2.05 Million	12,500 Added 52.52%	36,300 $481,000
Q4 2018 Feb 05, 2019	BUY	$81.94 - $139.71 $1.29 Million - $2.19 Million	15,700 Added 193.83%	23,800 $153,000
Q3 2018 Nov 07, 2018	BUY	$138.11 - $169.04 $179,543 - $219,752	1,300 Added 19.12%	8,100 $149,000
Q2 2018 Aug 10, 2018	SELL	$140.36 - $175.76 $238,612 - $298,792	-1,700 Reduced 20.0%	6,800 $144,000
Q1 2018 May 11, 2018	SELL	$152.15 - $192.33 $7.82 Million - $9.89 Million	-51,400 Reduced 85.81%	8,500 $202,000
Q4 2017 Jan 17, 2018	SELL	$60.72 - $167.34 $637,560 - $1.76 Million	-10,500 Reduced 14.91%	59,900 $3.97 Million
Q3 2017 Oct 17, 2017	BUY	$61.4 - $88.52 $4.32 Million - $6.23 Million	70,400	70,400 $411,000

Others Institutions Holding SAGE

# of Institutions

220

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$70.7 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$67.4 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$60.1 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$58.4 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$55.2 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account